ALDH1A1 and cancer: Both pegCAT and MitoTEMPO inhibited decreases in the expression of ALDH1 upon UDCA treatment (Figure 4C) pointing out that increases a more oxidative/nitrosative environment can reduce the proportions of cancer stem cells.